Nicorette study
This article was originally published in The Tan Sheet
Executive Summary
Smokers who used the smoking cessation gum even though they "were not ready to quit" were more likely to decrease daily cigarette consumption by at least 50% after one year compared to the placebo arm (8.8% versus 1.5% respectively), according to data collected in a Pfizer-sponsored, 411 smoker study conducted by P. Wennike et al. Presented at the World Conference on Tobacco or Health in early August, the study also shows a larger percentage of smokers who chew Nicorette stopped smoking completely compared to those taking placebo (11.2% versus 3.9%, respectively). GlaxoSmithKline markets Nicorette in the U.S through a licensing agreement with Pfizer...